Skip to content
OpenCapital
Get started

Sabra Healthcare SBRA Accounts Receivable, Credit Loss Expense (Reversal)

Accounts Receivable, Credit Loss Expense (Reversal) at other companies

Omega Healthcare Investors logo
Omega Healthcare InvestorsOHI
——

Other financials

Income statement

See full
Revenue$221.8M+20.8%
Net income$40.9M+1.4%
EPS (diluted)$0.16-5.9%

Balance sheet

See full
Cash & equivalents$116.5M+414%
Total debt$7.3M-9.6%
Total equity$2.8B+3.1%
Total assets$5.6B+6.8%

Cash flow

See full
Operating cash flow$98.4M+22.5%

Valuation

See full
Market cap$4.57B+16.7%

Profitability

See full
Net margin19.2%-0.3pp

Returns & leverage

See full
Return on equity5.7%+0.5pp
Debt / equity0×0.0×

Where this comes from

Reported directly by Sabra Healthcare in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The official record: Sabra Healthcare’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sabra Healthcare's accounts receivable, credit loss expense (reversal).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sabra Healthcare's accounts receivable, credit loss expense (reversal)?
Sabra Healthcare (SBRA) reported accounts receivable, credit loss expense (reversal) of -$213K in Q1 2026.
How has Sabra Healthcare's accounts receivable, credit loss expense (reversal) changed year-over-year?
Sabra Healthcare's accounts receivable, credit loss expense (reversal) decreased by 23.1% year-over-year, from -$173K to -$213K.
What is the long-term trend for Sabra Healthcare's accounts receivable, credit loss expense (reversal)?
Over 3 years (2021 to 2025), Sabra Healthcare's accounts receivable, credit loss expense (reversal) has grown at a -35.7% compound annual growth rate (CAGR), from $3.94M to -$1.05M.